Supported by a Research to Prevent Blindness Unrestricted Grant to th Variable definitions of quality standards pathologic makeup both need to be addressed when trying to make objective quality standards.e Cole Eye Institute (RPB1508DM) and by a grant from the National Institutes of Health (NIH K23-EY022947).
Disclosure: H.H. Li, None; J.R. Abraham, None; D.D. Sevgi, None; S.K. Srivastava, Regeneron (F), Allergan (F), Gilead (F), Bausch and Lomb (C), Santen (C), Leica (P); J.M. Hach, None; J. Whitney, None; A. Vasanji, ERT (E); J.L. Reese, None; J.P. Ehlers, Aerpio (C, F), Alcon (C, F), Thrombogenics/Oxurion (C, F), Regeneron (C, F), Genentech (C, F), Novartis (C, F), Allergan (C, F), Roche (C), Leica (C, P), Zeiss (C), Allegro (C), Santen (C)